Nowadays, most applications used for searching biomedical literatures are based on keyword technology, which is…
ENYO Pharma: Leveraging viruses to develop first-in-class drug candidates in many indications
In the last decade, the pharmaceutical sector has been facing structural issues when it comes to bringing new pharmaceuticals to the patient. Indeed, studies have revealed that the average cost to develop a single drug has tripled to greater than €1.7Bn in real terms since 2003 while numerous patent expirations have reduced revenues from blockbuster drugs…
Read More
The 10 Fastest Growing Pharmaceutical Companies 2017
Recent years have seen exciting discoveries in Pharma Industries that are generating truly novel therapeutics…
Executive Talk
Over recent years, more companies are incorporating wellness initiatives into their office environment. It’s mission…
Expert’s Column
American Medicine is in an unprecedented crisis. Doctors are not happy. A recent study by…
Professional’s Perticulars
For more than a decade hospital productivity has been a priority in Denmark. A focus…
Exclusive
The upsurge of e-learning technologies is evident in education all over the world. Communication and…
Market Dashboard
“The absence of pharma brands on social media creates a significant void of reputable healthcare…
Tech-N-Trends
The world is changing at an ever-increasing pace. Shopping malls have been replaced with online…
Insights Desk
